Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Delivered via once-weekly injection, this compounded therapy is offered exclusively through licensed providers
published in the Journal of Molecular Medicine identified VEGFR2 (vascular endothelial growth factor receptor 2) activation as a central mechanism of the BPC-157 peptides pro-angiogenic effects
AOD 9604 is a synthetic peptide fragment derived from human growth hormone (HGH)
Joint-related pain stems from many different factors
When Tesamorelin binds with the GHRH receptor in the pituitary glands, it stimulates the release of the growth hormone that sends signals to the liver to produce insulin-like growth factor-1 (IGF-1)
US$ 20.22
US$ 24.91
US$ 21.86
US$ 29.79
